Novo Nordisk’s etavopivat granted FDA orphan designation in thalassemia
Novo Nordisk’s (NVO) etavopivat was granted FDA orphan designation for treatment of thalassemias, according to a post on the agency’s ...
New Jersey Business Magazine23h
NJ’s Innovate100 Leaders to Be Honored May 13
On May 13, the INNOVATE100 leaders from across the state will be honored and celebrated in New Brunswick. These professionals ...